New Guideline Recommends Insulin Therapy in Some Younger Patients With Type 2 Diabetes

A new clinical practice guideline from the American Academy of Pediatrics (AAP) encourages physicians who are managing newly diagnosed type 2 diabetes in children and adolescents ages 10-18 years to use insulin as first-line treatment for patients who present with ketosis or frank ketoacidosis, as well as for those in whom "the distinction between type 1 and type 2 diabetes is not clear." Initiation of insulin therapy also may benefit children and teens who are markedly hyperglycemic but who show no evidence of ketosis or ketoacidosis. When glycemic control is restored, many of these patients can be weaned from insulin therapy.
Source: AAFP Health of the Public - Category: Primary Care Source Type: news